Contralateral Breast Cancer: Molecular Differentiation Between Metastasis and Second Primary Cancer
- 1 May 2001
- journal article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 67 (1) , 1-8
- https://doi.org/10.1023/a:1010661514306
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- The tp53 genotype but not immunohistochemical result is predictive of response to cisplatin-based neoadjuvant therapy in stage III non–small cell lung cancerThe Journal of Thoracic and Cardiovascular Surgery, 1999
- Consensus conference on the classification of ductal carcinoma in situHuman Pathology, 1997
- Detection of p53 Gene Abnormality by Sequence Analysis of Archival Paraffin TissueDiagnostic Molecular Pathology, 1996
- Molecular genetic differentiation between primary lung cancers and lung metastases of other tumorsThe Journal of Thoracic and Cardiovascular Surgery, 1996
- Survival of first and second primary breast cancerCancer, 1993
- The role and prognostic significance of p53 gene alterations in breast cancerBreast Cancer Research and Treatment, 1993
- Somatic mutations and human breast cancer. A Status ReportCancer, 1992
- Bilateral Breast CancerSurgical Clinics of North America, 1990
- Bilateral primary breast cancer: A prospective study of disease incidenceBritish Journal of Surgery, 1984
- Second primary cancers of the breast: Incidence and risk factorsBritish Journal of Cancer, 1984